期刊文献+

右美托咪定在谵妄患者撤机中的作用 被引量:11

原文传递
导出
摘要 在影响机械通气患者撤机的因素中,精神心理因素是一项重要的非呼吸因素.患者可由于精神心理原因导致呼吸机依赖和撤机失败,延长机械通气时间.谵妄、焦虑等精神状态改变也是自主呼吸试验(SBT)失败的指示因素.本院重症医学科2012年2月至2013年8月有7例患者由于谵妄导致SBT失败而应用右美托咪定,现对右美托咪定在谵妄患者撤机中的作用分析报告如下.
出处 《中华危重病急救医学》 CAS CSCD 北大核心 2014年第5期355-356,共2页 Chinese Critical Care Medicine
基金 中华医学会临床医学科研专项资金项目(13010090394)
  • 相关文献

参考文献18

  • 1Pun BT,Ely EW. The importance of diagnosing and managing ICU delirium[J].CHEST,2007,(02):624-636.
  • 2承韶晖,潘爱军,陈晓蓉,傅先明,钱若兵.重症监护病房患者谵妄发生率与识别率的现状[J].中国危重病急救医学,2012,24(8):493-494. 被引量:33
  • 3Pun BT,Dunn J. The sedation of critically ill adults:Part 1:Assessment.The first in a two-part series focuses on assessing sedated patients in the ICU[J].American Journal of Nursing,2007,(07):40-48.
  • 4Woods JC,Mion LC,Connor JT. Severe agitation among ventilated medical intensive care unit patients:frequency,characteristics and outcomes[J].Intensive Care Medicine,2004,(06):1066-1072.
  • 5MacIntyre NR,Cook DJ,Ely EW Jr. Evidence-based guidelines for weaning and discontinuing ventilatory support:a collective task force facilitated by the American College of Chest Physicians;the American.Association for Respiratory Care; and the American College of Critical Care Medicine[J].CHEST,2001,(6 Suppl):375S-395S.
  • 6Siegel MD. Management of agitation in the intensive care unit[J].CLINICS IN CHEST MEDICINE,2003,(04):713-725.
  • 7黄青青.右美托咪啶在重症监护病房中的应用[J].中国危重病急救医学,2010,22(10):578-580. 被引量:69
  • 8安友仲,邱海波,黄青青,康焰,管向东.中国重症加强治疗病房患者镇痛和镇静治疗指导意见(2006)[J].中华外科杂志,2006,44(17):1158-1166. 被引量:243
  • 9Hogarth DK,Hall J. Management of sedation in mechanically ventilated patients[J].CURRENT OPINION IN CRITICAL CARE,2004,(01):40-46.
  • 10裴皓.盐酸右美托咪定的药理作用与临床应用[J].医药导报,2010,29(12):1603-1607. 被引量:79

二级参考文献112

  • 1安友仲,邱海波,黄青青,康焰,管向东.中国重症加强治疗病房患者镇痛和镇静治疗指导意见(2006)[J].中华外科杂志,2006,44(17):1158-1166. 被引量:243
  • 2Jacobi J,Fraser GL,Coursin DB,et al.Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.Crit Care Med,2002,30:119-141.
  • 3Ostermann ME,Keenan SP,Seiferling RA,et al.Sedation in the intensive care unit:a systematic review.JAMA,2000,283:1451-1459.
  • 4Hayaahi Y,Maze M.Alpha2 adrenoceptor agonists and anaesthesia.Br J Anaesth,1993,71:108-118.
  • 5Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists,their pharmacology and therapeutic role.Anaesthesia,1999,54:146-165.
  • 6Bhana N,Goa KL,McClellan KJ.Dexmedetomidine.Drugs,2000,59:263-268.
  • 7Maze M,Scarfini C,Cavaliere F.New agents for sedation in the intensive care unit.Crit Care Clin,2001,17:881-897.
  • 8Venn RM,Bryant A,Hall GM,et al.Effects of dexmedetomidine on adrenocortical function,and the cardiovascular,endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit.Br J Anaesth,2001,86:650-656.
  • 9Herr DL,Sum-Ping ST,England M.ICU sedation after coronary artery bypass graft surgery:dexmedetomidine-based versus propofol-based sedation regimens.J Cardiothorac Vasc Anesth,2003,17:576-584.
  • 10Venn RM,Grounds RM.Comparison between dexmedetomidine and propofol for sedation in the intensive care unit:patient and clinician perceptions.Br J Anaesth,2001,87:684-690.

共引文献528

同被引文献156

引证文献11

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部